Sara Balduzzi

11.4k total citations · 5 hit papers
68 papers, 6.7k citations indexed

About

Sara Balduzzi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sara Balduzzi has authored 68 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Sara Balduzzi's work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (14 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Sara Balduzzi is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (14 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Sara Balduzzi collaborates with scholars based in Italy, Netherlands and Germany. Sara Balduzzi's co-authors include Gerta Rücker, Guido Schwarzer, Roberto D’Amico, Valentina Guarneri, L. Tagliabue, Lorenzo Moja, Vanna Pistotti, Elena Parmelli, Vittorio Basevi and Nicola Magrini and has published in prestigious journals such as Nature, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Sara Balduzzi

63 papers receiving 6.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How to perform a meta-analysis with R: a practical tutorial

2019 3.7k citations Sara Balduzzi, Gerta Rücker et al. profile →
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

2018 467 citations Holger J. Schünemann, Mary Cushman et al. Blood Advances profile →
Trastuzumab containing regimens for early breast cancer

2012 444 citations Sara Balduzzi, Valentina Guarneri et al. profile →
netmeta: An R Package for Network Meta-Analysis Using Frequentist Methods

2023 213 citations Sara Balduzzi, Gerta Rücker et al. Journal of Statistical Software profile →
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial

2024 40 citations Y.L. Verschoor, Sara Balduzzi et al. Nature Medicine profile →

Peers

Countries citing papers authored by Sara Balduzzi

Since Specialization

Citations

This map shows the geographic impact of Sara Balduzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Balduzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Balduzzi more than expected).

Fields of papers citing papers by Sara Balduzzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Balduzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Balduzzi. The network helps show where Sara Balduzzi may publish in the future.

Co-authorship network of co-authors of Sara Balduzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Balduzzi. A scholar is included among the top collaborators of Sara Balduzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Balduzzi. Sara Balduzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autism diagnosis in children and adolescents: A systematic review and meta-analysis of test accuracy 2025 ·Neuroscience & Biobehavioral Reviews ·Francesca Fulceri, Angela Caruso, Martina Micai, (unknown), Raffaella Tancredi, Laura Maria Fatta, (unknown), Roberto D’Amico, Holger J. Schünemann, Sara Balduzzi, Michela Cinquini, María Luisa Scattoni	0
2	Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Doenja M. J. Lambregts, Sara Balduzzi, Winnie Schats, Pétur Snæbjörnsson, Serena Marchetti, Marieke A. Vollebergh, (unknown), (unknown), Wouter V. Vogel, Zuhir Bodalal, (unknown), Oke Gerke, (unknown), Geerard L. Beets, Max J. Lahaye	5
3	Surgical navigation for targeted retroperitoneal lymph-node removal: a randomised, controlled, phase 3 trial 2024 ·EClinicalMedicine ·Harald C. Groen, Esther Wit, Wouter J. Heerink, Koert F.D. Kuhlmann, Jasper Nijkamp, (unknown), Ivo G. Schoots, Sara Balduzzi, Henry Zijlmans, Pim J. van Leeuwen, H.G. Van Der Poel, Theo J. M. Ruers	2
4	Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial breakdown → 2024 ·Nature Medicine ·(unknown), Y.L. Verschoor, (unknown), Sara Balduzzi, Hendrik A. Marsman, Marnix H. Geukes Foppen, Cecile Grootscholten, Simone Dokter, A.G. den Hartog, Wieke H.M. Verbeek, Karlijn Woensdregt, (unknown), Steven J. Oosterling, Ton N. Schumacher, Koert F.D. Kuhlmann, Regina G. H. Beets‐Tan, John B.A.G. Haanen, Monique E. van Leerdam, José G. van den Berg, Myriam Chalabi	40
5	503O Neoadjuvant nivolumab (nivo) plus relatlimab (rela) in MMR-deficient colon cancer: Results of the NICHE-3 study 2024 ·Annals of Oncology ·(unknown), Y.L. Verschoor, (unknown), Sara Balduzzi, (unknown), Cecile Grootscholten, Simone Dokter, A.G. den Hartog, Jacobus W. A. Burger, Wieke H.M. Verbeek, (unknown), Eduard R. Hendriks, Steven J. Oosterling, R.G.H. Beets-Tan, (unknown), J.B.A.G. Haanen, Koert F.D. Kuhlmann, Monique E. van Leerdam, José G. van den Berg, Myriam Chalabi	1
6	netmeta: An R Package for Network Meta-Analysis Using Frequentist Methods breakdown → 2023 ·Journal of Statistical Software ·Sara Balduzzi, Gerta Rücker, Adriani Nikolakopoulou, Theo Papakonstantinou, Georgia Salanti, Orestis Efthimiou, Guido Schwarzer	213
7	1219P Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma: The PANDA study 2022 ·Annals of Oncology ·Myriam Chalabi, Y.L. Verschoor, Joris van de Haar, (unknown), Liudmila L. Kodach, Johanna van Sandick, Jolanda van Dieren, Sara Balduzzi, (unknown), (unknown), Koen J. Hartemink, Marieke A. Vollebergh, (unknown), Annemarieke Bartels‐Rutten, (unknown), Monique E. van Leerdam, Ton N. Schumacher, J.B.A.G. Haanen, Emile E. Voest	3
8	41O Nine weeks vs 1-year adjuvant trastuzumab: Long term outcomes of the ShortHER randomised trial 2021 ·Annals of Oncology ·Pierfranco Conté, Antonio Frassoldati, Giancarlo Bisagni, Alba A. Brandes, Michela Donadio, Ornella Garrone, Federico Piacentini, Luigi Cavanna, Francesco Giotta, Michele Aieta, Vittorio Gebbia, Antonino Musolino, Antonella Ferro, Silvio Danese, Claudio Zamagni, Oriana Nanni, Maria Vittoria Dieci, Roberto Vicini, Sara Balduzzi, Valentina Guarneri	4
9	<p>Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy</p> 2019 ·Cancer Management and Research ·Claudia Omarini, (unknown), Annarita Pecchi, (unknown), Sara Balduzzi, (unknown), Monica Barbolini, (unknown), (unknown), Luca Moscetti, (unknown), Giovanni Tazzioli, Pietro Torricelli, Stefano Cascinu, Federico Piacentini	20
10	Formula feeding increases the risk of antibiotic prescriptions in children up to 2 years: results from a cohort study 2019 ·European Journal of Pediatrics ·(unknown), Simona Di Mario, Carlo Gagliotti, Andrea Donatini, (unknown), Rossella Buttazzi, Sara Balduzzi, (unknown), Vittorio Basevi, Luca Barbieri	5
11	American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients breakdown → 2018 ·Blood Advances ·Holger J. Schünemann, Mary Cushman, Allison Burnett, Susan R. Kahn, Jan Beyer‐Westendorf, Frederick A. Spencer, Suely Meireles Rezende, Neil A. Zakai, Kenneth A. Bauer, Francesco Dentali, Jill Lansing, Sara Balduzzi, Andrea Darzi, Gian Paolo Morgano, Ignacio Neumann, Robby Nieuwlaat, Juan José Yepes-Núñez, Yuan Zhang, Wojtek Wiercioch	467
12	9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 2018 ·Annals of Oncology ·Pierfranco Conté, Valentina Guarneri, Giancarlo Bisagni, Federico Piacentini, Alba A. Brandes, Luigi Cavanna, Francesco Giotta, Michele Aieta, Vittorio Gebbia, Antonio Frassoldati, Antonino Musolino, Ornella Garrone, (unknown), Anita Rimanti, Samanta Sarti, Daniela Rubino, Alessandra Bologna, Roberto Vicini, Sara Balduzzi, Roberto D’Amico	5
13	Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 2017 ·Acta Paediatrica ·Manuela Filippa, (unknown), Fabrizio Ferrari, (unknown), Pierre Kuhn, Sara Balduzzi, Roberto D’Amico	73
14	Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis 2017 ·BMC Infectious Diseases ·Giuseppe Pontrelli, Franco De Crescenzo, Roberto Buzzetti, Alessandro Jenkner, Sara Balduzzi, (unknown), Donato Amodio, Maia De Luca, Sara Chiurchiù, Elin Haf Davies, (unknown), Alessandra Simonetti, (unknown), Valeria Di Franco, (unknown), (unknown), (unknown), Marco Ciabattini, Susanna Livadiotti, Paolo Rossi	77
15	Outpatient parents’ views on shared-decision-making at an Italian children’s hospital 2016 ·Health Promotion International ·(unknown), (unknown), Roberto D’Amico, Sara Balduzzi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vincenzo Di Ciommo	6
16	Antibiotic Treatment of Severe Exacerbations of Chronic Obstructive Pulmonary Disease with Procalcitonin: A Randomized Noninferiority Trial 2015 ·PLoS ONE ·Alessia Verduri, Fabrizio Luppi, Roberto D’Amico, Sara Balduzzi, Roberto Vicini, (unknown), Valentina Ruggieri, Mario Plebani, Maria Pia Foschino Barbaro, Antonio Spanevello, Giorgio Walter Canonica, Alberto Papi, Leonardo M. Fabbri, Bianca Beghé, (unknown)	41
17	The TRIBECA study: (TRI)fecta (B)ioprosthesis (E)valuation versus (C)arpentier Magna-Ease in (A)ortic position 2015 ·European Journal of Cardio-Thoracic Surgery ·Andrea Colli, Giovanni Marchetto, Stefano Salizzoni, Mauro Rinaldi, Luca Di Marco, Davide Pacini, Roberto Di Bartolomeo, Francesco Nicolini, Tiziano Gherli, Marco Agrifoglio, Valentino Borghetti, (unknown), (unknown), (unknown), (unknown), Mário Jorge Amorim, Erica Manzan, Fabio Zucchetta, Sara Balduzzi, Gino Gerosa	36
18	Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 2013 ·PLoS ONE ·Bianca Beghé, Alessia Verduri, Barbara Bottazzi, Mariarita Stendardo, Alessandro Fucili, Sara Balduzzi, Chiara Leuzzi, Alberto Papi, Alberto Mantovani, Leonardo M. Fabbri, Claudio Ceconi, Piera Boschetto	18
19	The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass 2012 ·Journal of Cardiothoracic Surgery ·Andrea Colli, Sara Balduzzi, (unknown)	15
20	Herbal supplements in pregnancy: unexpected results from a multicentre study 2012 ·Human Reproduction ·Fabio Facchinetti, Giulia Pedrielli, G. Benoni, (unknown), Giovanna Verlato, Giulia Dante, Sara Balduzzi, Laura Cuzzolin	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact